This is not unique to the US. As we saw with the swine flu hysteria, the UN & governments world-wide, made decisions that benefited big pharmaceutical corporations. I won't rehash that news at this time. I will however, give you some of the latest news on this cozy relationship. Which benefits and enriches doctors & big pharma, but, not you.
You may have drugs pushed on you that are most definitely NOT to your benefit.
But very profitable. One that comes to mind have been the always questionable, but highly profitable statins. One specifically called Vytorin; Marketing triumphs science
More than 17,000 doctors and other health care providers have taken money from seven major drug companies to talk to other doctors about their products.
More than 380 of the doctors, nurses, pharmacists and other professionals took in more than $100,000 in 2009 and 2010.
"Tens of thousands of U.S. physicians are paid to spread the word about pharma's favored pills and to advise the companies about research and marketing," the group says in its report, available at http://www.propublica.org/topic/dollars-for-doctors.
The groups used information from seven drugmakers -- AstraZeneca, Cephalon, GlaxoSmithKline, Johnson & Johnson,( I am highlighting J & J because the next story will be about them specifically) Eli Lilly, Merck and Pfizer.
"Some of the companies were forced to disclose this information as a result of legal settlements; others released it voluntarily," Consumer Reports said. More than 70 other pharmaceutical companies have not disclosed payments made to doctors.
Kinda makes you wonder... when the doctor is writing that prescription for you are you really the beneficiary? Is this for your health? Or was he/she paid to do so, for the benefit of big pharma?Now let's take a look at Johnson & Johnson-
Johnson & Johnson CEO William Weldon delivered both a mea culpa and clear admission to lawmakers Thursday that his company let the public down through numerous recent drug recalls.
He also admitted that the company secretly bought up defective drugs without informing regulators and consumers of its actions.
Johnson & Johnson's McNeil recalled more than 135 million units of children's Tylenol, Benadryl and Motrin medicines in April, 2010 for possible bacterial contamination and the presence of small metal parts.
In May, McNeil shuttered its Fort Washington, PA plant. However, prior FDA inspection reports of the Fort Washington facility that makes all of McNeil's non-prescription liquid pediatric medicines and some adult drugs, showed a disturbing history of violations at the plant that worsened over the years.
Where was the FDA? Why did they do nothing to address years of failures?
Towns said Thursday's testimony indicates some very serious problems in "both with the way Johnson & Johnson viewed its responsibility to the public and its day-to-day relationship with the FDA."
"There is often a thin line between "working cooperatively" and having a "cozy relationship," he said. "The documents we have seen in this case indicate this line may have been crossed early and often."
The FDA and Johnston & Johnston, crossing the line in a "cozy relationship"